Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,149,000 | 4,970,000 | 3,468,000 | 1,667,000 | 4,572,000 |
| Depreciation Amortization | 1,302,000 | 942,000 | 591,000 | 282,000 | 1,154,000 |
| Income taxes - deferred | 342,000 | 114,000 | -8,000 | 31,000 | -540,000 |
| Accounts receivable | -2,138,000 | -1,751,000 | -1,632,000 | -1,258,000 | -256,000 |
| Accounts payable and accrued liabilities | 2,523,000 | 2,328,000 | 1,912,000 | 1,455,000 | 3,528,000 |
| Other Working Capital | 1,123,000 | 1,014,000 | 481,000 | 565,000 | 5,254,000 |
| Other Operating Activity | -937,000 | -925,000 | -624,000 | -237,000 | -3,024,000 |
| Operating Cash Flow | $8,364,000 | $6,692,000 | $4,188,000 | $2,505,000 | $10,688,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -956,000 | -1,030,000 | -642,000 | -731,000 | -849,000 |
| PPE Investments | -1,087,000 | -747,000 | -489,000 | -204,000 | -1,021,000 |
| Net Acquisitions | -3,476,000 | -3,442,000 | -3,442,000 | -27,000 | -1,976,000 |
| Purchase Of Investment | -18,669,000 | -15,130,000 | -11,221,000 | -6,978,000 | -19,492,000 |
| Sale Of Investment | 14,613,000 | 11,727,000 | 8,591,000 | 5,648,000 | 16,059,000 |
| Other Investing Activity | -63,000 | -50,000 | -29,000 | -15,000 | -45,000 |
| Investing Cash Flow | $-9,638,000 | $-8,672,000 | $-7,232,000 | $-2,307,000 | $-7,324,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,955,000 | 1,521,000 | 1,181,000 | 731,000 | 2,305,000 |
| Debt Issued | 3,462,000 | 3,312,000 | 3,762,000 | 3,212,000 | 2,334,000 |
| Debt Repayment | -1,068,000 | -954,000 | -952,000 | N/A | -1,932,000 |
| Common Stock Issued | 203,000 | 161,000 | 141,000 | 89,000 | 176,000 |
| Common Stock Repurchased | -1,900,000 | -1,378,000 | -927,000 | -447,000 | -2,700,000 |
| Dividend Paid | -1,104,000 | -831,000 | -555,000 | -277,000 | -954,000 |
| Other Financing Activity | -1,125,000 | -93,000 | -82,000 | 80,000 | -1,796,000 |
| Financing Cash Flow | $423,000 | $1,738,000 | $2,568,000 | $3,388,000 | $-2,567,000 |
| Exchange Rate Effect | -10,000 | -9,000 | -7,000 | -1,000 | 7,000 |
| Beginning Cash Position | 5,741,000 | 5,741,000 | 5,741,000 | 5,741,000 | 4,937,000 |
| End Cash Position | 4,880,000 | 5,490,000 | 5,258,000 | 9,326,000 | 5,741,000 |
| Net Cash Flow | $-861,000 | $-251,000 | $-483,000 | $3,585,000 | $804,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,364,000 | 6,692,000 | 4,188,000 | 2,505,000 | 10,688,000 |
| Capital Expenditure | -1,087,000 | -747,000 | -489,000 | -204,000 | -1,021,000 |
| Free Cash Flow | 7,277,000 | 5,945,000 | 3,699,000 | 2,301,000 | 9,667,000 |